At 7.8% CAGR, Nebulizer Market Size is expected to
Exhibit USD 1636.6 million by 2026, according to the analysis of MarketandReport.
Scope of the Report:
The detailed market intelligence report on the Global Nebulizer
Market Covers the most effective of each primary and secondary analysis to
weighs upon the competitive landscape and also the outstanding market players
expected to dominate Global Nebulizer Market place for the forecast 2019-2026.
Nebulizer Market Size, Share & Trends Analysis Report By
Type (Jet, Mesh, Ultrasonic), By End Use (Hospitals and Clinics, Emergency
Centers), By Region (North America, Europe, APAC, Latin America, MEA), And
Segment Forecasts, 2020 - 2026
The high growth is attributed to the rising incidence rate of chronic
respiratory diseases, increasing demand for home healthcare devices, and rising
geriatric population. As per lung.org, in 2018, Chronic Obstructive Pulmonary
Disease (COPD) is the leading cause of death in U.S.
Moreover, rising consumption of alcohol, tobacco,
ultra-processed products, including sugar-sweetened beverages is a major cause
behind the increasing prevalence of respiratory diseases in North America.
According to the Centers for Disease Control and Prevention (CDC) data, about
14% of deaths in adults aged 30 to 70 years in North America are caused due to
tobacco consumption. Thus, an increase in number of smokers and environmental
pollution is anticipated to increase the demand for nebulizers.
The Major Players are covered:
Teleflex Medical, Inc.
Trudell Medical International
PARI Respiratory Equipment,
Omron Healthcare, Inc.
Allied Healthcare Products,
GF HEALTH PRODUCTS, INC.
DeVilbiss Healthcare LLC
Koninklijke Philips N.V.
Rapid Transmission of
the COVID-19 Infection to Create Immediate Growth Opportunities
The SARS-CoV-2 infection attacks the respiratory tract and
lungs, causing shortness of breath, acute breathing problems, and pneumonia,
along with a persistent fever and cough. People with preexisting lung disorders
such as asthma are at high risk of contracting the COVID-19 infection.
According to the Centers for Disease Control and Prevention (CDC), asthma
patients are highly recommended to carry inhalers or portable Nebulizer with
them as these devices can efficiently open the lungs and allow them to function
normally. In this scenario, the uptake of inhalable drug delivery devices is
likely to spike and favor the Nebulizer market growth. The only worry with
these devices, as pointed out by the Asthma and Allergy Foundation of America,
is their potential to transmit the infection among patients as well as
healthcare workers, especially in healthcare facilities. If this issue is
addressed, players can capitalize on the current pandemic and expand their presence
in the market.
Infrastructure to Support Market Growth in North America
North America boasted a market size of USD 308.4 million in
2019 and the region is likely to lead the Nebulizer market share during the
forecast period. This is chiefly attributable to the presence of a robust
healthcare infrastructure and patient-friendly reimbursement policies. In
addition to this, escalating number of COVID-19 cases in the US will skyrocket
the demand for Nebulizer and inhalers in 2020. Similar trends are expected to
be observed in Europe. On the other hand, the market is Asia-Pacific is slated
for steady expansion owing to the proliferation of medical device companies and
rising prevalence of chronic respiratory disorders.
Respiratory illnesses have become a major concern around the
globe. Rising burden of chronic respiratory diseases such as asthma, chronic
obstructive pulmonary disease (COPD), cystic fibrosis, and increasing adoption
of sedentary lifestyle are likely to accelerate the demand for effective drug
delivery devices, further propelling this market growth. According to a report
published by Forum of International Respiratory Societies (FIRS), in 2019,
around 384 million people suffered from chronic obstructive pulmonary disease
(COPD) and the number of cases is anticipated to surge in the coming
years. A significant growth in
population along with the rise in air pollution and increase in the smoking
rates in the emerging economies are anticipated to escalate the incidence of
respiratory diseases in emerging countries. Moreover, the changing pattern of
asthma with the age and rise in the incidence childhood asthma are likely to
boost the usage of portable devices during the forecast period. According to
American Lung Association (ALA), in 2016 in the U.S., approximately 3.5 million
children below 18 years suffered an asthma attack. The increasing incidence of
asthma in children is anticipated to fortify the demand for these devices
during the forecast period.
For Detailed Report Request a Sample Report.